Kura Oncology
Price & Volume
Stats
See more52W Range | $5.41-$19.93 |
Market Cap | $785.5M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $83.2M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$114.8M |
Diluted EPS | -$2.25 |
News
See moreYahoo Finance • 3 days ago
Kura Oncology and Kyowa Kirin Announce Publication of Pivotal Ziftomenib Data in Relapsed/Refractory NPM1-Mutated AML in the Journal of Clinical Oncology
Yahoo Finance • 4 days ago
Kura Oncology to Participate in Upcoming Investor Conference
Yahoo Finance • 12 days ago
Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types
Yahoo Finance • 23 days ago
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Troy Edward Wilson J.D., Ph.D. |
Address | 12730 High Bluff Drive, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 192 |
